Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer

Published:2017-03-30 Issue:5 Volume:6 Page:753-757
ISSN:2049-9450
Container-title:Molecular and Clinical Oncology
language:en
Short-container-title:

Author:

Tajima Hidehiro,Ohta Tetsuo,Shinbashi Hiroyuki,Hirose Atsushi,Okazaki Mitsuyoshi,Yamaguchi Takahisa,Ohbatake Yoshinao,Okamoto Koichi,Nakanuma Shinichi,Sakai Seisho,Kinoshita Jun,Makino Isamu,Nakamura Keishi,Hayashi Hironori,Oyama Katsunobu,Inokuchi Masafumi,Miyashita Tomoharu,Takamura Hiroyuki,Ninomiya Itasu,Fushida Sachio,Nakamura Hiroyuki

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and laboratory parameters in patients across metastatic tumor sites;International Journal of Molecular and Immuno Oncology;2024-07-24

2. Paclitaxel Restores Sensitivity to Chemotherapy in Preclinical Models of Multidrug-Resistant Intrahepatic Cholangiocarcinoma;Frontiers in Oncology;2022-02-17

3. What is the real value of metronomic chemotherapy in the treatment of gastrointestinal cancer?;Expert Opinion on Pharmacotherapy;2021-06-24

4. Nab-paclitaxel - Third-line chemotherapy in advanced gallbladder cancer;Indian Journal of Medical Research;2020

5. Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives;Expert Opinion on Pharmacotherapy;2019-09-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP